Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

McGraw Hill, Inc. Exceeds Fiscal Year 2026 Guidance Driven by Re-Occurring Revenue Growth and Delivers Positive Net Income

businesswire.com

McGraw Hill, Inc. Exceeds Fiscal Year 2026 Guidance Driven by Re-Occurring Revenue Growth and Delivers Positive Net Income COLUMBUS, Ohio--( BUSINESS WIRE)--McGraw Hill, Inc. (NYSE: MH) (“McGraw Hill” or the “Company”), a leading global provider of education solutions for preK-12, higher education and professional learning, today announced financial results for the fiscal fourth quarter 2026 and year-end March 31, 2026.

Key Fiscal Year 2026 Financial Highlights

“McGraw Hill’s growth in fiscal year 2026 underscores the strength of our strategy, the speed of our innovation and the depth of trust that we have from the education community,” said Philip Moyer, President and Chief Executive Officer of the Company and a member of the Company’s Board of Directors. “This past year, we released more new curriculum offerings and learning tools than during any time in our history, reached record engagement levels, and achieved a new high‑water mark for customer satisfaction. We have achieved over 7.5 million users of our new AI personalized learning tools and now have an existing base of more than 100 million active student and educator curriculum licenses in over 100 countries. With over 25 billion learning interactions and 190 terabytes of data across our platforms, we are delivering a new generation of precision learning at a global scale that few can match. Equally exciting, we are preparing to pilot our new Agentic AI version of our precision education model, and we intend to be a leader in creating a vibrant ‘cloud’ knowledge offering in the world of education and learning. Our momentum in fiscal year 2026 positions us well to accelerate growth and expand margins in fiscal year 2027 and beyond.”

“Fiscal year 2026 was a transformative year for McGraw Hill—marked by our initial public offering and the growth of our Company, notwithstanding a smaller K-12 market opportunity, expanding profitability and significant debt reduction,” said Bob Sallmann, McGraw Hill’s Executive Vice President and Chief Financial Officer. “Our disciplined execution delivered results above guidance across revenue, re-occurring revenue and Adjusted EBITDA while strengthening our balance sheet and cash generation. With $646 million in gross debt reduction, we have increased our financial flexibility and expanded margins while simultaneously investing in the business to position the Company for sustained long-term growth. As we enter fiscal year 2027, our focus remains on growth acceleration, operating efficiency and employing a balanced approach to capital allocation as we continue to reduce gross debt, grow the business and strengthen returns.”

Fiscal Year 2026 Strategic Highlights

Fourth Quarter and Fiscal Year 2026 Financial Highlights

Three Months Ended March 31,

Year Ended March 31,

($ in thousands)

2026

2025

2026

2025

(unaudited)

Revenue

$

463,722

$

473,262

$

2,102,781

$

2,101,299

Cost of sales (excluding depreciation and amortization)

$

74,834

$

78,393

$

401,139

$

422,294

Operating and administrative expenses

$

282,023

$

292,535

$

1,080,250

$

1,066,496

Net income (loss)

$

(50,267

)

$

(156,867

)

$

35,320

$

(85,839

)

Adjusted EBITDA (1)

$

130,575

$

131,651

$

744,264

$

726,790

Net income (loss) margin

(10.8

)%

(33.1

)%

1.7

%

(4.1

)%

Adjusted EBITDA Margin (1)

28.2

%

27.8

%

35.4

%

34.6

%

Adjusted net income (loss) (1)

$

61,167

$

(328,084

)

$

375,459

$

202,350

Fiscal Fourth Quarter Consolidated Financial Highlights

Fiscal Fourth Quarter and Full Year Segment Highlights

Higher Education

K-12

Global Professional and International

Fiscal Year 2027 Guidance

The following fiscal year 2027 guidance is forward-looking, and is based on the Company’s current expectations. Actual results may differ materially from what is indicated below.

Fiscal Year 2027 Guidance

As of June 11, 2026

($ in millions)

Low

High

Revenue

$

2,115

$

2,175

Re-occurring Revenue

1,587

1,627

Adjusted EBITDA (1)

750

790

Share Repurchase Plan

On June 2, 2026, our Board of Directors approved a share repurchase plan whereby, from time to time, the Company may repurchase up to $50 million of the Company’s common stock.

Earnings Conference Call and Webcast

Today, June 11, 2026, at 8:30 a.m. ET, McGraw Hill will host a conference call via webcast to review fiscal year 2026 fourth quarter and full year results and provide a business update. The webcast will be hosted by Simon Allen, Chair of the Board of Directors, Philip Moyer, President and Chief Executive Officer, and Bob Sallmann, Executive Vice President and Chief Financial Officer, and will conclude with a question-and-answer session.

To access the live webcast or to view a replay, visit the Company's investor relations website at https://investors.mheducation.com/

The live question and answer portion of the call can be accessed by registering online at the Event Registration Page at which time registrants will receive dial-in information as well as a conference ID. Registration can be completed in advance of the conference call.

About McGraw Hill

McGraw Hill (NYSE: MH) is a leading global provider of education solutions for preK-12, higher education and professional learning, supporting the evolving needs of millions of educators and students around the world. We provide trusted, high-quality content and personalized learning experiences that use data, technology and learning science to help students progress towards their goals. Through our commitment to fostering a culture of innovation and belonging, we are dedicated to improving outcomes and access to education for all. We have over 30 offices across North America, Asia, Australia, Europe, the Middle East and South America, and make our learning solutions available in more than 80 languages. The Company’s fiscal year is the 52-week period ended March 31. Visit us at mheducation.com or find us on Facebook, Instagram, LinkedIn or X.

Safe Harbor Statement

This press release includes statements that are, or may be deemed to be, “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by the use of forward-looking terminology, including terms such as “believes,” “estimates,” “anticipates,” “expects,” “projects,” “intends,” “plans,” “may,” “will,” “should” or “seeks,” or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts and include, but are not limited to, statements regarding the Company’s intentions, beliefs or current expectations concerning, among other things, the Company’s results of operations, financial condition, liquidity, prospects, growth, strategies and the industry in which it operates. By their nature, forward-looking statements involve risks and uncertainties, as they relate to events and depend on circumstances that may or may not occur in the future. The Company’s expectations, beliefs and projections are expressed in good faith, and the Company believes there is a reasonable basis for them; however, the Company cautions readers that forward-looking statements are not guarantees of future performance and that the Company’s actual results of operations, financial condition and liquidity, and the developments in the industry in which the Company operates, may differ materially from those made in or suggested by the forward-looking statements contained in this press release. There are a number of risks, uncertainties and other important factors that could cause our actual results to differ materially from the forward-looking statements contained in this press release, including those described under the headings “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, and in other filings made with the U.S. Securities and Exchange Commission. In addition, even if our results of operations, financial condition and liquidity, and the developments in the industry in which we operate are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in subsequent periods. Any forward-looking statements the Company makes in this press release speak only as of the date of such statement. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities law.

(1) Non-GAAP Financial Measures

In addition to presenting financial results that have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”), we have included in this release the following non-GAAP financial measures—EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted net income (loss), Adjusted basic and diluted earnings (loss) per share, Adjusted operating and administrative expenses, Adjusted selling and marketing expenses, Adjusted general and administrative expenses, Adjusted research and development expenses and Net Leverage Ratio. All such financial measures are not required by or presented in accordance with GAAP. We believe that these non-GAAP financial measures are useful in evaluating our business and the underlying trends that affect our performance. The Company has included non-GAAP financial measures within the meaning of Regulation G and Item 10(e) of Regulation S-K. We include these non-GAAP financial measures in this release because management uses them to assess our performance. We believe that they reflect the underlying trends and indicators of our business and allow management to focus on the most meaningful indicators of our continuous operational performance. Although we believe these measures are useful for investors for the same reasons, readers of the financial statements herein should note that these measures are not a substitute for GAAP financial measures or disclosures. Each of these measures is not a recognized term under GAAP and does not purport to be an alternative to net income (loss), or any other measure derived in accordance with GAAP as a measure of operating performance, or to cash flows from operations as a measure of liquidity. Such measures are presented for supplemental information purposes only, have limitations as analytical tools and should not be considered in isolation or as substitute measures for our results as reported under GAAP. Management uses non-GAAP financial measures to supplement GAAP results to provide a more complete understanding of the factors and trends affecting our business, rather than evaluating GAAP results alone. Because not all companies use identical calculations, our measures may not be comparable to other similarly titled measures of other companies, and our use of these measures varies from others in our industry. Such measures are not intended to be a measure of cash available for management’s discretionary use, as they may not capture actual cash obligations associated with interest payments, other debt service requirements and taxes. Because of these limitations, we rely primarily on our GAAP results and use these non-GAAP measures only supplementally. See “Reconciliations of Non-GAAP Financial Measures” in the “Supplemental Information” section below and “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Non-GAAP Financial Measures” in our Annual Report on Form 10-K filed on June 11, 2026, for reconciliations of non-GAAP financial measures to the most directly comparable financial measure stated in accordance with GAAP.

(2) Learning interactions measures the volume of user-driven educational activities across McGraw Hill platforms, including answering questions, completing assignments, and engaging with learning content. This data captures activity across K-12 platforms (Open Learning, ConnectED, ALEKS), Higher Education (Smartbook, Connect), and Enterprise IDM. For the fiscal year ended March 31, 2026, coverage expanded to include A3K Literacy, Actively Learn, and additional Connect data.

Forward-Looking Non-GAAP Financial Measures

This press release contains forward-looking estimates of Adjusted EBITDA for fiscal year 2027. We provide this non-GAAP measure to investors on a prospective basis for the same reasons (as set forth above) that we provide it to investors on a historical basis. We are unable to provide a reconciliation of our forward-looking estimate of fiscal year 2027 net income (loss) to a forward-looking estimate of fiscal year 2027 Adjusted EBITDA because certain information needed to make a reasonable forward-looking estimate of net income (loss) for fiscal year 2027 is unreasonably difficult to predict and estimate and is often dependent on future events that may be uncertain or outside of our control. In addition, we believe such reconciliations would imply a degree of precision that would be confusing or misleading to investors. The unavailable information could have a significant impact on our future financial results. Our forward-looking estimates of both GAAP and non-GAAP measures of our financial performance may differ materially from our actual results and should not be relied upon as statements of fact.

MCGRAW HILL, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Dollars in thousands, except for share and per share data)

Three Months Ended March 31,

Year Ended March 31,

2026

2025

2026

2025

(unaudited)

Revenue

$

463,722

$

473,262

$

2,102,781

$

2,101,299

Cost of sales (excluding depreciation and amortization)

74,834

78,393

401,139

422,294

Gross profit

388,888

394,869

1,701,642

1,679,005

Operating expenses

Operating and administrative expenses

282,023

292,535

1,080,250

1,066,496

Depreciation

19,767

16,240

81,985

66,688

Amortization of intangibles

54,460

58,322

223,627

239,014

Impairment charge

39,000

39,000

Total operating expenses

395,250

367,097

1,424,862

1,372,198

Operating income (loss)

(6,362

)

27,772

276,780

306,807

Interest expense (income), net

45,154

63,547

207,226

293,446

(Gain) loss on extinguishment of debt

1,222

25,766

2,719

Income (loss) from operations before taxes

(52,738

)

(35,775

)

43,788

10,642

Income tax provision (benefit)

(2,471

)

121,092

8,468

96,481

Net income (loss)

$

(50,267

)

$

(156,867

)

$

35,320

$

(85,839

)

Basic earnings (loss) per share

$

(0.26

)

$

(0.94

)

$

0.19

$

(0.52

)

Diluted earnings (loss) per share

$

(0.26

)

$

(0.94

)

$

0.19

$

(0.52

)

(1) See “Supplemental Information—Reconciliations of Non-GAAP Financial Measures; Non-GAAP operating and administrative expenses” for a breakdown of our GAAP operating and administrative expenses and a reconciliation to the corresponding Non-GAAP financial measure.

MCGRAW HILL, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Dollars in thousands, except for share data)

March 31, 2026

March 31, 2025

Assets

Current assets

Cash and cash equivalents

$

253,519

$

389,830

Accounts receivable, net of allowance for credit losses of $14,517 and $13,521 as of March 31, 2026 and 2025, respectively

362,483

338,426

Inventories, net

195,022

174,018

Prepaid and other current assets

162,625

150,357

Total current assets

973,649

1,052,631

Product development costs, net

285,970

222,182

Property, plant and equipment, net

90,421

95,197

Goodwill

2,522,595

2,557,595

Other intangible assets, net

1,227,253

1,454,185

Deferred income taxes

8,572

7,983

Operating lease right-of-use assets

44,836

49,661

Other non-current assets

332,225

318,326

Total assets

$

5,485,521

$

5,757,760

Liabilities and stockholders' equity (deficit)

Current liabilities

Accounts payable

$

126,701

$

146,742

Accrued royalties

81,436

71,457

Accrued compensation

108,434

124,954

Deferred revenue

835,357

794,031

Current portion of long-term debt

13,170

13,170

Operating lease liabilities

8,365

8,042

Other current liabilities

93,086

172,023

Total current liabilities

1,266,549

1,330,419

Long-term debt

2,560,698

3,164,551

Deferred income taxes

15,214

15,656

Long-term deferred revenue

836,001

882,156

Operating lease liabilities

57,301

64,737

Other non-current liabilities

23,540

19,997

Total liabilities

4,759,303

5,477,516

Commitments and contingencies

Stockholders' equity (deficit)

Class A voting common stock, par value $0.01 per share; 186,471,212 shares authorized, 165,160,216 shares issued and outstanding as of March 31, 2025

1,652

Class B non-voting common stock, par value $0.01 per share; 14,384,922 shares authorized, 1,451,303 shares issued and outstanding as of March 31, 2025

14

Common Stock, par value $0.01 per share; 2,000,000,000 shares authorized, 191,146,027 shares issued and outstanding as of March 31, 2026; and no shares authorized, issued and outstanding as of March 31, 2025

1,911

Additional paid-in capital

1,972,702

1,562,204

Accumulated deficit

(1,245,880

)

(1,281,200

)

Accumulated other comprehensive income (loss)

(2,515

)

(2,426

)

Total stockholders' equity (deficit)

726,218

280,244

Total liabilities and stockholders' equity (deficit)

$

5,485,521

$

5,757,760

MCGRAW HILL, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in thousands)

Three Months Ended March 31,

Year Ended March 31,

2026

2025

2026

2025

(unaudited)

Operating activities

Net income (loss)

$

(50,267

)

$

(156,867

)

$

35,320

$

(85,839

)

Adjustments to reconcile net income (loss) to net cash provided by operating activities

Depreciation (including amortization of technology costs)

19,767

16,240

81,985

66,688

Amortization of intangibles

54,460

58,322

223,627

239,014

Amortization of product development costs

11,344

11,952

56,306

56,655

Amortization of deferred royalties

8,532

10,639

76,186

75,919

Amortization of deferred commission costs

6,466

6,357

22,449

19,092

Stock-based compensation

1,986

33,723

Credit losses on accounts receivable

2,838

5,324

2,309

2,768

Unrealized (gain) loss on interest rate cap

235

Inventory obsolescence

886

3,229

9,186

13,013

Deferred income taxes

(1,900

)

(286

)

(1,055

)

(1,470

)

Amortization of debt discount

3,053

5,733

13,000

20,722

Amortization of deferred financing costs

1,199

1,713

4,943

10,495

(Gain) loss on extinguishment of debt

1,222

25,766

2,719

Impairment charge

39,000

39,000

Changes in operating assets and liabilities:

Accounts receivable

(123,535

)

(12,057

)

(22,902

)

(12,490

)

Inventories

(26,335

)

(25,697

)

(29,467

)

26,299

Prepaid and other current assets

(35,152

)

27,618

(127,979

)

(99,627

)

Accounts payable and accrued expenses

4,003

45,389

(21,265

)

85,541

Deferred revenue

(25,138

)

(72,011

)

(6,174

)

166,550

Other current liabilities

(42,069

)

16,201

(84,192

)

46,854

Other changes in operating assets and liabilities, net

3,516

17,016

407

13,146

Cash provided by (used for) operating activities

(146,124

)

(41,185

)

331,173

646,284

Investing activities

Product development expenditures

(42,321

)

(29,524

)

(119,001

)

(90,000

)

Capital expenditures

(23,823

)

(28,441

)

(84,862

)

(71,062

)

Acquisition of EssayPop

(6,000

)

(6,000

)

Cash provided by (used for) investing activities

(66,144

)

(63,965

)

(203,863

)

(167,062

)

Financing activities

Borrowings on 2024 Secured Notes

650,000

Payment of A&E Term Loan Facility

(10,000

)

(53,293

)

(605,575

)

(156,585

)

Payment of Term Loan Facility

(754,875

)

Repurchase of 2022 Unsecured Notes

(39,895

)

(39,895

)

Payment of deferred financing costs

(24,027

)

Payment of finance lease obligations

(810

)

(1,485

)

(6,722

)

(9,193

)

Proceeds from issuance of common stock in Initial Public Offering, net of underwriting discounts

392,862

Deferred Initial Public Offering costs

(7,037

)

Issuance of Common Stock

1,500

1,500

Cash provided by (used for) financing activities

(49,205

)

(54,778

)

(264,867

)

(294,680

)

Effect of exchange rate changes on cash

600

774

1,246

1,670

Net change in cash and cash equivalents

(260,873

)

(159,154

)

(136,311

)

186,212

Cash and cash equivalents, at the beginning of the period

514,392

548,984

389,830

203,618

Cash and cash equivalents, at the end of the period

$

253,519

$

389,830

$

253,519

$

389,830

Supplemental disclosures

Cash paid for interest expense

$

83,253

$

101,338

$

207,932

$

274,730

Cash paid for income taxes

2,750

13,519

76,582

46,920

Supplemental Information

Reconciliations of Non-GAAP Financial Measures

EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin

“EBITDA” is defined as net income (loss) from continuing operations plus interest expense (income), net, income tax provision (benefit), depreciation and amortization.

“Adjusted EBITDA” is defined as net income (loss) from continuing operations plus interest expense (income), net, income tax provision (benefit), depreciation and amortization, restructuring and cost savings implementation charges, the effects of the application of purchase accounting, advisory fees paid to Platinum Advisors pursuant to the Advisory Agreement (which was terminated on July 25, 2025 in connection with the consummation of our initial public offering), impairment charges, transaction and integration costs, stock-based compensation, (gain) loss on extinguishment of debt and the impact of earnings or charges resulting from matters that we do not consider indicative of our ongoing operations.

Further, although not included in the calculation of Adjusted EBITDA below, we may at times add estimated cost savings and operating synergies related to operational changes ranging from acquisitions or dispositions to restructurings, and exclude one-time transition expenditures.

“Adjusted EBITDA Margin” is calculated by dividing Adjusted EBITDA by total revenue.

The following table presents a reconciliation of EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin to the most directly comparable GAAP financial measure for the periods presented.

Three Months Ended March 31,

Year Ended March 31,

2026

2025

2026

2025

($ in thousands)

(unaudited)

Net income (loss)

$

(50,267

)

$

(156,867

)

$

35,320

$

(85,839

)

Interest expense (income), net

45,154

63,547

207,226

293,446

Income tax provision (benefit)

(2,471

)

121,092

8,468

96,481

Depreciation, amortization and product development amortization

85,571

86,514

361,918

362,357

EBITDA

$

77,987

$

114,286

$

612,932

$

666,445

Restructuring and cost savings implementation charges (a)

2,402

7,616

11,176

24,626

Advisory fees (b)

2,500

3,125

10,000

Impairment charge (c)

39,000

39,000

Transaction and integration costs (d)

373

462

1,191

2,982

Stock-based compensation (e)

1,986

33,723

Gain (loss) on extinguishment of debt (f)

1,222

25,766

2,719

Other (g)

7,605

6,787

17,351

20,018

Adjusted EBITDA (h)

$

130,575

$

131,651

$

744,264

$

726,790

Total Revenue

$

463,722

$

473,262

$

2,102,781

$

2,101,299

Net income (loss) margin

(10.8

)%

(33.1

)%

1.7

%

(4.1

)%

Adjusted EBITDA Margin

28.2

%

27.8

%

35.4

%

34.6

%

__________________

(a) Represents severance and other expenses associated with headcount reductions and other cost savings initiated as part of our restructuring initiatives.

(b) For the fiscal year ended March 31, 2026, represents the pro rata portion of the annual $10.0 million advisory fee paid to Platinum Advisors pursuant to the Advisory Agreement through its termination on July 25, 2025 in connection with the consummation of our initial public offering. For the fiscal year ended March 31, 2025, represents $10.0 million of annual advisory fees paid to Platinum Advisors pursuant to the Advisory Agreement. For the three months ended March 31, 2025, represents the quarterly portion of such annual advisory fee.

(c) For the three months ended March 31, 2026 and the fiscal year ended March 31, 2026, we recorded an impairment charge of $39.0 million, related to our International goodwill and indefinite-lived intangible trademark.

(d) This primarily represents transaction and integration costs associated with acquisitions.

(e) Represents stock-based compensation expense related to awards granted to our employees, directors and consultants under the Company's long-term incentive plans.

(f) For the three months ended March 31, 2026, the amount represents accelerated amortization of debt discount and deferred financing costs associated with the repayment of $40.0 million face value of the 2022 Unsecured Notes and $6.7 million of debt outstanding under the A&E Term Loan Facility.

For the fiscal year ended March 31, 2026, the amount represents accelerated amortization of debt discount and deferred financing costs related to (i) the repayment of $385.7 million of debt outstanding under the A&E Term Loan Facility using net proceeds from our initial public offering on July 25, 2025, (ii) the repayment of an additional $206.7 million of debt outstanding under the A&E Term Loan Facility during the second half of fiscal year 2026, and (iii) the repayment of $40.0 million face value of the 2022 Unsecured Notes during the fourth fiscal quarter of 2026.

For the fiscal year ended March 31, 2025, the amount represents accelerated amortization of debt discount and deferred financing costs associated with the August 6, 2024 refinancing of the Term Loan Facility.

(g) For the three months ended March 31, 2026 and 2025, this amount represents (i) foreign currency exchange transaction impact of $(0.1) million and $(0.3) million, respectively, (ii) non-recurring expenses related to strategic initiatives, including marketing, consulting, and non-operational costs associated with the market introduction of a new product launch of $3.7 million and $1.2 million, respectively, (iii) reimbursements of expenses paid to Platinum Advisors incurred in connection with its services under the Advisory Agreement (which was terminated on July 25, 2025 in connection with the consummation of our initial public offering) of $0.5 million and $0.2 million, respectively, (iv) non-recurring transaction-related costs associated with our initial public offering that were expensed as incurred of nil and $1.8 million, respectively, (v) lease termination costs of nil and $3.3 million, respectively, associated with the early exit of a leased property in connection with the strategic rationalization of our real estate properties to optimize cost efficiency, and (vi) the impact of additional insignificant earnings or charges resulting from matters that we do not consider indicative of our ongoing operations of $3.5 million and $0.6 million, respectively, that are primarily related to individually insignificant miscellaneous items, including third-party consulting and advisory fees associated with system and process rationalization initiatives and certain additional payments related to incremental insurance premiums and policies as a result of the Platinum acquisition that did not renew after the consummation of our initial public offering.

For the fiscal years ended March 31, 2026 and 2025, the amount represents (i) foreign currency exchange transaction impact of $(2.3) million and $1.3 million, respectively, (ii) non-recurring expenses related to strategic initiatives, including marketing, consulting, and non-operational costs associated with the market introduction of a new product launch of $9.2 million and $4.3 million, respectively, (iii) reimbursements of expenses paid to Platinum Advisors incurred in connection with its services under the Advisory Agreement (which was terminated on July 25, 2025 in connection with the consummation of our initial public offering) of $0.8 million and $0.6 million, respectively, (iv) non-recurring transaction-related costs associated with our initial public offering that were expensed as incurred of $2.8 million and $4.9 million, respectively, (v) lease termination costs of nil and $3.3 million, respectively, associated with the early exit of a leased property in connection with the strategic rationalization of our real estate properties to optimize cost efficiency, (vi) post-acquisition compensation expense of nil and $0.6 million, respectively, associated with the acquisition of Boards & Beyond, and (vii) the impact of additional insignificant earnings or charges resulting from matters that we do not consider indicative of our ongoing operations of $6.9 million and $5.0 million, respectively, primarily related to individually insignificant miscellaneous items, including asset dispositions, third-party consulting and advisory fees associated with system and process rationalization initiatives, as well as certain additional payments related to incremental insurance premiums and policies as a result of the Platinum acquisition that did not renew after the consummation of our initial public offering.

(h) The purchase accounting adjustment included in the definition of Adjusted EBITDA is not presented in the table above, as there were no such charges recognized during the three months ended March 31, 2026 and 2025 and the fiscal years ended March 31, 2026 and 2025.

Adjusted net income (loss) and Adjusted basic and diluted earnings (loss) per share

“Adjusted net income (loss)” is defined as net income (loss) from continuing operations adjusted to exclude amortization of intangible assets, restructuring and cost savings implementation charges, the effects of the application of purchase accounting, advisory fees paid to Platinum Advisors pursuant to the Advisory Agreement (which was terminated on July 25, 2025 in connection with the consummation of our initial public offering), impairment charges, transaction and integration costs, stock-based compensation, (gain) loss on extinguishment of debt and the impact of earnings or charges resulting from matters that we do not consider indicative of our ongoing operations and the related tax impact of those adjustments.

“Adjusted basic and diluted earnings (loss) per share” is calculated by dividing Adjusted net income (loss) by the basic and diluted weighted average shares outstanding.

The following table presents a reconciliation of Adjusted net income (loss) and Adjusted basic and diluted earnings (loss) per share to the most directly comparable GAAP financial measure for the periods presented.

Three Months Ended March 31,

Year Ended March 31,

2026

2025

2026

2025

($ in thousands)

(unaudited)

Net income (loss)

$

(50,267

)

$

(156,867

)

$

35,320

$

(85,839

)

Amortization of intangible assets (1)

54,298

58,125

222,932

238,240

Restructuring and cost savings implementation charges (2)

2,402

7,616

11,176

24,626

Advisory fees (2)

2,500

3,125

10,000

Impairment charge (2)

39,000

39,000

Transaction and integration costs (2)

373

462

1,191

2,982

Stock-based compensation (2)

1,986

33,723

Gain (loss) on extinguishment of debt (2)

1,222

25,766

2,719

Other (2)

7,605

6,787

17,351

20,018

Tax impact of adjustments (3)

4,548

(246,707

)

(14,125

)

(10,396

)

Adjusted net income (loss)

$

61,167

$

(328,084

)

$

375,459

$

202,350

Basic earnings (loss) per share

$

(0.26

)

$

(0.94

)

$

0.19

$

(0.52

)

Diluted earnings (loss) per share

$

(0.26

)

$

(0.94

)

$

0.19

$

(0.52

)

Adjusted basic earnings (loss) per share

$

0.32

$

(1.97

)

$

2.05

$

1.21

Adjusted diluted earnings (loss) per share (4)

$

0.32

$

(1.97

)

$

2.04

$

1.21

Basic weighted-average shares outstanding

191,066,548

166,611,519

183,466,677

166,611,519

Diluted weighted-average shares outstanding

191,066,548

166,611,519

183,670,022

166,611,519

_____________

(1) Represents amortization of definite-lived acquired intangible assets.

(2) Represents the same adjustments used in calculating EBITDA and Adjusted EBITDA.

(3) Represents the tax impact of these adjustments, which are pre-tax, based upon the effective income tax rate.

(4) For the three months ended March 31, 2026, the Company reported a net loss and, accordingly, all potentially dilutive securities were considered anti-dilutive and excluded from the calculation of diluted earnings (loss) per share. However, because the Company reported Adjusted net income for the same period, these potentially dilutive securities were included in the calculation of Adjusted diluted earnings (loss) per share, resulting in diluted weighted-average shares outstanding of 191,105,182. There were no potentially dilutive securities issued during the three months ended March 31, 2025.

Non-GAAP operating and administrative expenses

“Adjusted operating and administrative expenses” is defined as GAAP operating and administrative expenses adjusted to exclude restructuring and cost savings implementation charges, advisory fees paid to Platinum Advisors pursuant to the Advisory Agreement (which was terminated on July 25, 2025 in connection with the consummation of our initial public offering), transaction and integration costs, stock-based compensation, amortization of product development costs and the impact of earnings or charges resulting from matters that we do not consider indicative of our ongoing operations.

“Adjusted selling and marketing expenses” is defined as GAAP selling and marketing expenses adjusted to exclude stock-based compensation and the impact of earnings or charges resulting from matters that we do not consider indicative of our ongoing operations.

“Adjusted general and administrative expenses” is defined as GAAP general and administrative expenses adjusted to exclude restructuring and cost savings implementation charges, advisory fees paid to Platinum Advisors pursuant to the Advisory Agreement (which was terminated on July 25, 2025 in connection with the consummation of our initial public offering), transaction and integration costs, stock-based compensation and the impact of earnings or charges resulting from matters that we do not consider indicative of our ongoing operations.

“Adjusted research and development expenses” is defined as GAAP research and development expenses adjusted to exclude stock-based compensation and the impact of earnings or charges resulting from matters that we do not consider indicative of our ongoing operations.

The following table presents a reconciliation of these non-GAAP operating and administrative expenses to the most directly comparable GAAP financial measure for the periods presented.

Three Months Ended March 31,

Year Ended March 31,

2026

2025

2026

2025

($ in thousands)

(unaudited)

Operating and administrative expenses

$

282,023

$

292,535

$

1,080,250

$

1,066,496

Restructuring and cost savings implementation charges

(2,402

)

(7,616

)

(11,176

)

(24,626

)

Advisory fees

(2,500

)

(3,125

)

(10,000

)

Transaction and integration costs

(373

)

(462

)

(1,191

)

(2,982

)

Amortization of product development costs

(11,344

)

(11,952

)

(56,306

)

(56,655

)

Stock-based compensation

(1,986

)

(33,723

)

Other

(7,605

)

(6,787

)

(17,351

)

(20,018

)

Adjusted operating and administrative expenses (1)

$

258,313

$

263,218

$

957,378

$

952,215

Selling and marketing

$

101,565

$

104,375

$

378,719

$

380,199

Stock-based compensation

(19

)

(1,180

)

Other

(2,856

)

(743

)

(6,922

)

(3,210

)

Adjusted selling and marketing expenses (1)

$

98,690

$

103,632

$

370,617

$

376,989

General and administrative

$

95,485

$

88,853

$

368,972

$

345,213

Restructuring and cost savings implementation charges

(2,402

)

(7,616

)

(11,176

)

(24,626

)

Advisory fees

(2,500

)

(3,125

)

(10,000

)

Transaction and integration costs

(373

)

(462

)

(1,191

)

(2,982

)

Stock-based compensation

(1,919

)

(27,428

)

Other

(4,010

)

(5,655

)

(8,500

)

(15,747

)

Adjusted general and administrative expenses (1)

$

86,781

$

72,620

$

317,552

$

291,858

Research and development

$

73,629

$

87,355

$

276,253

$

284,429

Stock-based compensation

(48

)

(5,115

)

Other

(739

)

(389

)

(1,929

)

(1,061

)

Adjusted research and development expenses (1)

$

72,842

$

86,966

$

269,209

$

283,368

_____________

(1) We calculate each of these measures by using the same adjustments used in calculating EBITDA and Adjusted EBITDA to the extent such items are included in the corresponding GAAP operating and administrative expense category.

Net Leverage Ratio

“Net Leverage Ratio“ is calculated by dividing net debt as of the most recent balance sheet date by the Last Twelve Months (“LTM”) Adjusted EBITDA. Net debt is defined as Gross Debt, net of cash and cash equivalents. Gross Debt is defined as the total amount of principal borrowings outstanding.

LTM is defined as the twelve-month period ended on the last day of the most recently completed fiscal quarter. LTM Adjusted EBITDA is equal to Adjusted EBITDA for the fiscal year ended March 31, 2026.

As of March 31,

($ in thousands)

2026

A&E Term Loan Facility due 2031

$

554,840

2022 Secured Notes due 2028

828,466

2024 Secured Notes due 2031

650,000

First Lien Indebtedness

$

2,033,352

2022 Unsecured Notes due 2029

599,034

Gross Debt

$

2,632,386

Cash and cash equivalents

(253,519

)

Net Debt

$

2,378,867

LTM Adjusted EBITDA (1)

$

744,264

Net Leverage Ratio (2)

3.2x

__________

(1) LTM Adjusted EBITDA is equal to Adjusted EBITDA for the fiscal year ended March 31, 2026.

(2) In addition to the Net Leverage Ratio, the Company is subject to a Consolidated First Lien Net Leverage Ratio springing covenant, pursuant to its credit agreement. The Consolidated First Lien Net Leverage Ratio is calculated by dividing Consolidated First Lien Secured Debt by LTM Consolidated Adjusted EBITDA, as such terms are defined in our credit agreements. As of March 31, 2026, the Consolidated First Lien Net Leverage Ratio was 2.4x. The Consolidated First Lien Secured Debt was $1,795,896 as of March 31, 2026, and is defined as First Lien Indebtedness of $2,033,352 plus capital lease obligations of $16,063, net of cash and cash equivalents of $253,519. LTM Consolidated Adjusted EBITDA is Consolidated Adjusted EBITDA for the fiscal year ended March 31, 2026 of $751,803. Consolidated Adjusted EBITDA differs from Adjusted EBITDA presented elsewhere herein and is defined in our credit agreements.

Key Operating Metrics

Re-occurring Revenue and Transactional Revenue

Three Months Ended March 31,

2026

2025

Re-occurring

Revenue

Transactional

Revenue

Total

Re-occurring

Revenue

Transactional

Revenue

Total

($ in thousands)

(unaudited)

(unaudited)

K-12

$

109,142

$

17,071

$

126,213

$

112,384

$

28,446

$

140,830

Higher Education

217,106

41,144

258,250

228,307

25,807

254,114

Global Professional

25,141

13,729

38,870

24,480

13,876

38,356

International

22,110

18,705

40,815

21,839

21,186

43,025

Other

(426

)

(426

)

(3,063

)

(3,063

)

Total Revenue

$

373,499

$

90,223

$

463,722

$

387,010

$

86,252

$

473,262

Year Ended March 31,

2026

2025

($ in thousands)

Re-occurring

Revenue

Transactional

Revenue

Total

Re-occurring

Revenue

Transactional

Revenue

Total

K-12

$

619,725

$

264,755

$

884,480

$

602,040

$

368,444

$

970,484

Higher Education

734,353

144,601

878,954

666,748

115,862

782,610

Global Professional

98,746

51,330

150,076

95,094

54,494

149,588

International

88,143

98,542

186,685

92,959

108,443

201,402

Other

2,586

2,586

(2,785

)

(2,785

)

Total Revenue

$

1,540,967

$

561,814

$

2,102,781

$

1,456,841

$

644,458

$

2,101,299

Remaining Performance Obligation (RPO)

March 31, 2026

March 31, 2025

($ in thousands)

Current

Non-current

Total

Current

Non-current

Total

RPO by Segment:

K-12

$

477,183

$

772,190

$

1,249,373

$

457,353

$

822,232

$

1,279,585

Higher Education

268,649

53,350

321,999

247,685

49,631

297,316

Global Professional

58,186

7,791

65,977

54,949

7,399

62,348

International

30,394

2,670

33,064

30,513

2,894

33,407

Other

945

945

3,531

3,531

Total RPO

$

835,357

$

836,001

$

1,671,358

$

794,031

$

882,156

$

1,676,187

Net Dollar Retention

Net dollar retention “NDR” is calculated by dividing (a) the digital subscription amounts invoiced to existing customers during the year, inclusive of changes in enrollment, price changes and attrition by (b) the digital subscription amounts invoiced to such customers for the comparable prior year.

Digital and Print Revenue

Disaggregation of Revenue - Print and Digital

Three Months Ended March 31,

2026

2025

Digital

Print (1)

Total

Digital

Print (1)

Total

($ in thousands)

(unaudited)

(unaudited)

Revenue by Segment:

K-12

$

98,898

$

27,315

$

126,213

$

102,030

$

38,800

$

140,830

Higher Education

241,799

16,451

258,250

249,100

5,014

254,114

Global Professional

27,577

11,293

38,870

26,254

12,102

38,356

International

24,442

16,373

40,815

23,624

19,401

43,025

Other (2)

(426

)

(426

)

(3,063

)

(3,063

)

Total Revenue

$

392,716

$

71,006

$

463,722

$

401,008

$

72,254

$

473,262

Year Ended March 31,

2026

2025

($ in thousands)

Digital

Print (1)

Total

Digital

Print (1)

Total

Revenue by Segment:

K-12

$

429,644

$

454,836

$

884,480

$

430,546

$

539,938

$

970,484

Higher Education

799,898

79,056

878,954

723,066

59,544

782,610

Global Professional

107,120

42,956

150,076

102,996

46,592

149,588

International

96,986

89,699

186,685

102,719

98,683

201,402

Other (2)

2,586

2,586

(2,785

)

(2,785

)

Total Revenue

$

1,433,648

$

669,133

$

2,102,781

$

1,359,327

$

741,972

$

2,101,299

___________________

(1)

Print revenue contains print and multi-year print products.

(2)

Includes in-transit product sales and intersegment revenue adjustments that are not included within segment revenues reviewed by the Company's Chief Operating Decision Maker.